Marché de la fabrication sous contrat en Amérique du Nord – Tendances et prévisions du secteur jusqu’en 2030

Analyse et perspectives du marché de la fabrication sous contrat en Amérique du Nord

Le marché de la fabrication sous contrat en Amérique du Nord est stimulé par des facteurs tels que les progrès techniques croissants et la rentabilité des produits pharmaceutiques et des produits en cours de développement, ce qui accroît la demande, ainsi que l'augmentation des investissements dans la recherche et le développement, qui entraînent la croissance du marché. Actuellement, les dépenses de santé ont augmenté dans les pays développés et émergents, ce qui devrait créer un avantage concurrentiel pour les fabricants qui souhaitent développer des produits nouveaux et innovants.

La fabrication sous contrat est un contrat entre une entreprise et un fabricant pour fabriquer un certain nombre de composants ou de produits pour l'entreprise dans un délai déterminé. Les biens créés seront sous la marque de l'entreprise. On parle alors de fabrication sous marque privée. On parle aussi souvent d'externalisation si elle est réalisée au-delà des frontières. Les fabricants fournissent leurs services sur la base de leurs propres conceptions, formules et spécifications, à moins que le client ne fournisse les siennes. Ils créeront ces produits pour quiconque aura conclu un contrat, même pour des entreprises concurrentes.

L'un des principaux facteurs à l'origine de la croissance du marché de la fabrication sous contrat est la demande croissante dans le secteur des dispositifs médicaux et pharmaceutiques en Amérique du Nord. Les recherches continues sur les essais cliniques menées par plusieurs entreprises pour un meilleur diagnostic conduisent à l'expansion du marché. Le marché est également influencé par les progrès technologiques croissants et la rentabilité. Cependant, le risque d'informations confidentielles et les réglementations strictes peuvent constituer des facteurs restrictifs pour le marché de la fabrication sous contrat en Amérique du Nord au cours de la période de prévision

D'un autre côté, l'expiration des brevets et la demande croissante de médicaments génériques, les dépenses croissantes en infrastructures de santé et les initiatives stratégiques des principaux acteurs du marché constituent des opportunités de croissance pour le marché. Cependant, le risque de propriété intellectuelle et le nombre croissant de sociétés pharmaceutiques souhaitant créer leurs propres unités de fabrication peuvent créer des défis pour le marché nord-américain de la fabrication sous contrat.

La demande de fabrication sous contrat va augmenter en Amérique du Nord en raison d'une tendance croissante vers les diagnostics au point de service . Diverses entreprises prennent des initiatives qui conduisent progressivement à la croissance du marché.

The North America contract manufacturing market is supportive and aims to reduce the manufacturing efforts of healthcare organizations. Data Bridge Market Research analyses that the North America contract manufacturing market will grow at a CAGR of 6.8% during the forecast period of 2023 to 2030.

North America Contract Manufacturing Dynamics

Market Definition

Contract manufacturing in international markets is used in situations when one company arranges for another company in a different country to manufacture its products; this is also known as international subcontracting or international outsourcing. The company provides the manufacturer with all the specifications, and, if applicable, also with the materials required for the production process. This type of contract sets out the requirements, which the manufacturer must meet concerning the quality of the products, certification, quantities, conditions and dates of delivery, etc. It also establishes guidelines for the inspection and testing of the products set forth by the company which contracts out the manufacture, or by its own clients. Furthermore, it also outlines modifications to orders, as well as guarantees and compensation in case of breach of contract. Since the process is essentially outsourcing production in foreign markets to a partner that privately brands the end product, there are a number of different companies and industries that can make use of this type of contract.

Drivers

• Cost-effectiveness for the manufacturing companies

The time-consuming manufacturing and ineffective production for several things and management are major burdens for public and private sector organizations. They are also essential for addressing complex challenges because a single organization is less effective in driving the change and sometimes required outcomes. The contract manufacturing companies will act as rising opportunities for both governmental and private sectors

The rising demand for contract manufacturing with improved accuracy and less time constraint pushes the key players for strategic initiatives. Owning contract manufacturing frees up the overhead charges required to invest in machinery, material, and another workforce, simplifying the production process and streamlining the supply chain by reducing the overall cost.

However, major market players are investing heavy capital in manufacturing to reach the demands of their end users. The contract manufacturing players are involved in making the strategies and implementing them by reducing the cost of production of these players. Contract manufacturing services to other firms also ensure efficiency and optimum usage of resources by using effective workforce, strategic intelligence, or working resources required in the production cycle.

• Rise of technological advancements in contract manufacturing

Introducing a new drug in the market promptly requires considerable investments in manufacturing due to the escalated demand in the pharmaceutical industry. Advanced technologies and skills are mandatory as some drugs have complex formulas and require specific equipment and techniques when mass-produced.

The usage of innovative technologies such as machine learning, big data, and artificial intelligence to develop pharmaceutical drugs or manufacture medical devices are being considered for rapid and quick manufacturing. These technical advancements also help in mass production and scalability in a short span of time.

However, pharmaceutical firms conventionally audit or supervise their contract manufacturing organization's production and delivery processes to monitor the manufacturing process using real-time remote tracing.

Opportunities

• Growing expenses on the development of healthcare infrastructure

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population. Infrastructure must integrate the hospital, as the center for acute and inpatient care, into the broader healthcare system and should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements: equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff.

However, the growing expenses on the development of healthcare infrastructure are propelling the growth of the North America contract manufacturing market in the forecast period.

Restraints/Challenges

• Increase in the Number of Pharmaceutical Companies Set Up Their Manufacturing Sites

Most pharmaceutical companies are building manufacturing sites to produce pharmaceutical products to reduce costs. Manufacturers are more focused on introducing advanced technologies and the digitalization process. The Pharma industry also faces disruptions due to new business models and a more focused population on personalized medicines and treatments. Hence, the demand for personalized care is high. Occupational profiles are also changing: some jobs are disappearing due to automation while entirely new jobs are emerging.

Hence, the increasing number of pharmaceutical companies setting up their manufacturing units may challenge the growth of the North America contract manufacturing market in the forecast period.

Recent Developments

• In October 2021, Boehringer Ingelheim International gmbh., had inaugurated its state-of-the-art biopharmaceutical production facility Large Scale Cell Culture (LSCC) in Vienna, Austria, with an investment volume of more than 700 million EUR, which is the single largest investment in the company's history
• In March 2023, Evonik Industries AG has announced that it is opening a new GMP facility to manufacture lipids for advanced, pharmaceutical drug delivery applications. The lipid launch facility is located at the company’s site in Hanau, Germany and provides customers with quantities of lipids as needed for clinical and small-scale commercial manufacturing

North America Contract Manufacturing Market Segmentation

The North America contract manufacturing market is categorized into three notable segments based on product, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product

• Medical Device Manufacturing
• Pharmaceutical Products Manufacturing

On the basis of product, the North America contract manufacturing market is segmented into medical device manufacturing and pharmaceutical products manufacturing.

End User

• Pharmaceutical Companies
• Biotechnology Companies
• Biopharma Companies
• Medical Device Companies
• Original Equipment Manufacturer
• Research Institutes

On the basis of end user, the North America contract manufacturing market is segmented into original equipment manufacturer, medical device companies, pharmaceutical companies, biotechnology companies, biopharma companies, and research institutes.

Distribution Channel

• Retail Sales
• Direct Tender
• Others

On the basis of distribution channel, the North America contract manufacturing market is segmented into direct tenders, retail sales, and others.

North America Contract Manufacturing Market Regional Analysis/Insights

The North America contract manufacturing market is analyzed, and market size insights and trends are provided by product, end user, and distribution channel as referenced above.

The countries covered in the contract manufacturing report are U.S., Canada, Mexico.

Les États-Unis devraient dominer le marché en raison des progrès technologiques croissants dans les régions en développement.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques nord-américaines et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché du secteur de la fabrication sous contrat en Amérique du Nord

Le paysage concurrentiel du marché de la fabrication sous contrat en Amérique du Nord fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Amérique du Nord, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement de produits, la largeur et l'étendue des produits et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché de la fabrication sous contrat en Amérique du Nord.

Certains acteurs du marché sont Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH. et Catalent, Inc. entre autres.

SKU-69920